Eric D. Donnenfeld, MD; underscores the significance of an FDA approved treatment for Demodex blepharitis as well as past alternative treatments. This is a video synopsis/summary of an Insights ...
Glaukos Corp. (GKOS) announced an update on their ongoing clinical study. Glaukos Corp. (GKOS) is running a Phase 2 trial titled “Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel ...
Dr Shamie shares her optimism in the advancement of Demodex Blepharitis treatment. This is a video synopsis/summary of an Insights involving Neda Shamie, MD. With an FDA-approved treatment now ...
Preoperative identification and eradication of Demodex can improve ocular-surface comfort and may mitigate cataract-surgery ...
Modern Vision Solutions has announced the publication of a new article, “Demodex Blepharitis Treatment in Omaha,” highlighting a significant shift in how optometrists approach the treatment of chronic ...
To better understand the experience of those living with eye mites, we spoke to one optometrist and two people who have had ...
Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults. XDEMVY is indicated for all adult patients with Demodex blepharitis and is available ...
IRVINE, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that a $15 million milestone payment due Tarsus has been achieved following regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results